Skip to main content

Advertisement

Log in

Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Inhibition of lysine deacetylase (KDAC) attenuated development of hypertension in spontaneously hypertensive rats (SHRs). We hypothesized that KDAC inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptors (MR) instead of histone acetylation in SHRs. Valproate (VPA, 0.71 % wt/vol), an inhibitor of class I KDACs, was administered in drinking water to 7-week-old SHRs and Wistar Kyoto rats for 11 weeks. MR acetylation was determined by immunoprecipitation with anti-MR antibody followed by western blot with anti-acetyl-lysine antibody. Expression levels of acetylated histone H3, KDACs, MR target genes, or MR corepressors in the kidney cortex were measured by using western blot analysis or real-time PCR. Recruitment of MR and RNA polymerase II (Pol II) and histone modifications on promoters of target genes were analyzed by performing a chromatin immunoprecipitation (ChIP) assay. Treatment of SHR with VPA increased MR acetylation without affecting MR expression, which attenuated development of hypertension in SHR VPA decreased expression of KDAC class I but globally increased acetylated histone H3. Although VPA treatment increased histone 3 acetylation (H3Ac) and trimethylation of the fourth lysine (H3K4me3) in the promoter regions of MR target genes, it decreased the expression of target genes as well as recruitment of MR and Pol II. These results suggest that KDAC inhibition attenuates the development of hypertension in SHRs and is accompanied by acetylation of MR that is independent of histone acetylation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

ALDO:

Aldosterone

ATP1a1:

Na+-K+-APTase subunit α1

ChIP:

Chromatin immunoprecipitation

EGFR:

Epidermal growth-factor receptor

ENaC:

Epithelial Na+ channel

GILZ:

Glucocorticoid-induced leucine zipper protein

GR:

Glucocorticoid receptor

HAT:

Histone acetyltransferase

HRE:

Hormone response element

KDAC:

Lysine deacetylase

MR:

Mineralocorticoid receptor

Pol II:

RNA polymerase II

SGK1:

Serum and glucocorticoid-regulated kinase 1

SHR:

Spontaneously hypertensive rats

VPA:

Valproate

References

  • Bolden JE, Peart MJ, Johnstone RW (2006) Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5:769–784

    Article  CAS  PubMed  Google Scholar 

  • Buchwald M, Kramer OH, Heinzel T (2009) HDACi—targets beyond chromatin. Cancer Lett 280:160–167

    Article  CAS  PubMed  Google Scholar 

  • Cardinale JP, Sriramula S, Pariaut R, Guggilam A, Mariappan N, Elks CM, Francis J (2010) HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats. Hypertension 56:437–444

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chapman N, Dobson J, Wilson S, Dahlof B, Sever PS, Wedel H, Poulter NR (2007) Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 49:839–845

    Article  CAS  PubMed  Google Scholar 

  • Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325:834–840

    Article  CAS  PubMed  Google Scholar 

  • Coffey K, Robson CN (2012) Regulation of the androgen receptor by post-translational modifications. J Endocrinol 215:221–237

    Article  CAS  PubMed  Google Scholar 

  • Connell JM, MacKenzie SM, Freel EM, Fraser R, Davies E (2008) A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev 29:133–154

    Article  CAS  PubMed  Google Scholar 

  • Daniel AR, Gaviglio AL, Czaplicki LM, Hillard CJ, Housa D, Lange CA (2010) The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention. Mol Endocrinol 24:2126–2138

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Galmozzi A, Mitro N, Ferrari A, Gers E, Gilardi F, Godio C, Cermenati G, Gualerzi A, Donetti E, Rotili D, Valente S, Guerrini U, Caruso D, Mai A, Saez E, De Fabiani E, Crestani M (2013) Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue. Diabetes 62:732–742

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Grossmann C, Ruhs S, Langenbruch L, Mildenberger S, Stratz N, Schumann K, Gekle M (2012) Nuclear shuttling precedes dimerization in mineralocorticoid receptor signaling. Chem Biol 19:742–751

    Article  CAS  PubMed  Google Scholar 

  • Haberland M, Montgomery RL, Olson EN (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10:32–42

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hargovan M, Ferro A (2014) Aldosterone synthase inhibitors in hypertension: current status and future possibilities. JRSM Cardiovasc Dis 3:2048004014522440

    PubMed  PubMed Central  Google Scholar 

  • Iyer A, Fenning A, Lim J, Le GT, Reid RC, Halili MA, Fairlie DP, Brown L (2010) Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats. Br J Pharmacol 159:1408–1417

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kouzarides T (2007) Chromatin modifications and their function. Cell 128:693–705

    Article  CAS  PubMed  Google Scholar 

  • Le Menuet D, Isnard R, Bichara M, Viengchareun S, Muffat-Joly M, Walker F, Zennaro MC, Lombes M (2001) Alteration of cardiac and renal functions in transgenic mice overexpressing human mineralocorticoid receptor. J Biol Chem 276:38911–38920

    Article  PubMed  Google Scholar 

  • Lee HA, Lee DY, Cho HM, Kim SY, Iwasaki Y, Kim IK (2013) Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension. Circ Res 112:1004–1012

    Article  CAS  PubMed  Google Scholar 

  • McGraw AP, McCurley A, Preston IR, Jaffe IZ (2013) Mineralocorticoid receptors in vascular disease: connecting molecular pathways to clinical implications. Curr Atheroscler Rep 15:340

    Article  PubMed  PubMed Central  Google Scholar 

  • Morrell MJ, Isojarvi J, Taylor AE, Dam M, Ayala R, Gomez G, O’Neill F, Tennis P, Messenheimer J (2003) Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy. Epilepsy Res 54:189–199

    Article  CAS  PubMed  Google Scholar 

  • Nader N, Chrousos GP, Kino T (2009) Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications. FASEB J 23:1572–1583

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nagai Y, Miyata K, Sun GP, Rahman M, Kimura S, Miyatake A, Kiyomoto H, Kohno M, Abe Y, Yoshizumi M, Nishiyama A (2005) Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts. Hypertension 46:1039–1045

    Article  CAS  PubMed  Google Scholar 

  • Nakagaki T, Hirooka Y, Matsukawa R, Nishihara M, Nakano M, Ito K, Hoka S, Sunagawa K (2012) Activation of mineralocorticoid receptors in the rostral ventrolateral medulla is involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats. Hypertens Res 35:470–476

    Article  CAS  PubMed  Google Scholar 

  • Nightingale KP, Gendreizig S, White DA, Bradbury C, Hollfelder F, Turner BM (2007) Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation. J Biol Chem 282:4408–4416

    Article  CAS  PubMed  Google Scholar 

  • Perico N, Benigni A, Remuzzi G (2008) Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection. Nat Rev Drug Discov 7:936–953

    Article  CAS  PubMed  Google Scholar 

  • Pinto V, Pinho MJ, Silva E, Simao S, Igreja B, Afonso J, Serrao MP, Gomes P, Soares-da-Silva P (2012) Long-term food restriction attenuates age-related changes in the expression of renal aldosterone-sensitive sodium transporters in Wistar-Kyoto rats: a comparison with SHR. Exp Gerontol 47:644–653

    Article  CAS  PubMed  Google Scholar 

  • Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309–1321

    Article  CAS  PubMed  Google Scholar 

  • Qiu Y, Zhao Y, Becker M, John S, Parekh BS, Huang S, Hendarwanto A, Martinez ED, Chen Y, Lu H, Adkins NL, Stavreva DA, Wiench M, Georgel PT, Schiltz RL, Hager GL (2006) HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Mol Cell 22:669–679

    Article  CAS  PubMed  Google Scholar 

  • Rice JC, Allis CD (2001) Histone methylation versus histone acetylation: new insights into epigenetic regulation. Curr Opin Cell Biol 13:263–273

    Article  CAS  PubMed  Google Scholar 

  • Rossig L, Li H, Fisslthaler B, Urbich C, Fleming I, Forstermann U, Zeiher AM, Dimmeler S (2002) Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis. Circ Res 91:837–844

    Article  PubMed  Google Scholar 

  • Sasaki S, Nakata T, Kawasaki S, Hayashi J, Oguro M, Takeda K, Nakagawa M (1990) Chronic central GABAergic stimulation attenuates hypothalamic hyperactivity and development of spontaneous hypertension in rats. J Cardiovasc Pharmacol 15:706–713

    Article  CAS  PubMed  Google Scholar 

  • Seo M, Song M, Seok YM, Kang SH, Lee HA, Sohn UD, Kim IK (2015) Lysine acetyltransferases cyclic adenosine monophosphate response element-binding binding protein and acetyltransferase p300 attenuate transcriptional activity of the mineralocorticoid receptor through its acetylation. Clin Exp Pharmacol Physiol 42:559–566

    Article  CAS  PubMed  Google Scholar 

  • Shibata H, Ando T, Suzuki T, Kurihara I, Hayashi K, Hayashi M, Saito I, Murai M, Saruta T (1998) COUP-TFI expression in human adrenocortical adenomas: possible role in steroidogenesis. J Clin Endocrinol Metab 83:4520–4523

    Article  CAS  PubMed  Google Scholar 

  • Singh BN, Zhang G, Hwa YL, Li J, Dowdy SC, Jiang SW (2010) Nonhistone protein acetylation as cancer therapy targets. Expert Rev Anticancer Ther 10:935–954

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stockand JD (2002) New ideas about aldosterone signaling in epithelia. Am J Physiol Renal Physiol 282:F559–F576

    Article  PubMed  Google Scholar 

  • Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403:41–45

    Article  CAS  PubMed  Google Scholar 

  • Tao H, Shi KH, Yang JJ, Huang C, Zhan HY, Li J (2014) Histone deacetylases in cardiac fibrosis: current perspectives for therapy. Cell Signal 26:521–527

    Article  CAS  PubMed  Google Scholar 

  • van der Laan S, Sarabdjitsingh RA, Van Batenburg MF, Lachize SB, Li H, Dijkmans TF, Vreugdenhil E, de Kloet ER, Meijer OC (2008) Chromatin immunoprecipitation scanning identifies glucocorticoid receptor binding regions in the proximal promoter of a ubiquitously expressed glucocorticoid target gene in brain. J Neurochem 106:2515–2523

    Article  PubMed  Google Scholar 

  • Verrotti A, D’Egidio C, Mohn A, Coppola G, Chiarelli F (2011) Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications. Obes Rev 12:e32–e43

    Article  CAS  PubMed  Google Scholar 

  • Viengchareun S, Le Menuet D, Martinerie L, Munier M, Pascual-Le Tallec L, Lombes M (2007) The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology. Nucl Recept Signal 5:e012

    PubMed  PubMed Central  Google Scholar 

  • Wang C, Fu M, Angeletti RH, Siconolfi-Baez L, Reutens AT, Albanese C, Lisanti MP, Katzenellenbogen BS, Kato S, Hopp T, Fuqua SA, Lopez GN, Kushner PJ, Pestell RG (2001) Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity. J Biol Chem 276:18375–18383

    Article  CAS  PubMed  Google Scholar 

  • Wang C, Tian L, Popov VM, Pestell RG (2011) Acetylation and nuclear receptor action. J Steroid Biochem Mol Biol 123:91–100

    Article  CAS  PubMed  Google Scholar 

  • Yang XJ, Seto E (2008) Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol Cell 31:449–461

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yang J, Young MJ (2009) The mineralocorticoid receptor and its coregulators. J Mol Endocrinol 43:53–64

    Article  CAS  PubMed  Google Scholar 

  • Zhao L, Chen CN, Hajji N, Oliver E, Cotroneo E, Wharton J, Wang D, Li M, McKinsey TA, Stenmark KR, Wilkins MR (2012) Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid. Circulation 126:455–467

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) (2013R1A1A2058145 and 2013R1A2A2A01005155), funded by the Ministry of Education, Science and Technology, and the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI13C1527).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to In Kyeom Kim.

Ethics declarations

This investigation was conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and was approved by the Institutional Review Board of Kyungpook National University (KNU 2012–116), and every effort was made to minimize both the number of animals used and their suffering.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Young Mi Seok and Hae Ahm Lee contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(PPTX 111 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seok, Y.M., Lee, H.A., Park, K.M. et al. Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats. Naunyn-Schmiedeberg's Arch Pharmacol 389, 799–808 (2016). https://doi.org/10.1007/s00210-016-1246-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-016-1246-2

Keywords

Navigation